AQW 30159/17-22 Written question to the Minister of Health

To ask the Minister of Health to detail the comparison between the funding required for anti-viral treatments for COVID-19 and the funding required for support in hospital short of mechanical ventilation.

Asked by Paula Bradshaw MLA on 23 February 2022

  • Answered
  • Written
  • After due date
Tabled
23 February 2022
Answer due by
10 March 2022
Answered
25 March 202230 days after tabling
Department
Department of Health
Priority question
No

Answer

COVID-19 antivirals and monoclonal antibody treatments (nMAbs) are currently funded by the Department of Health and Social Care (DHSC) through central procurement on behalf of the four UK countries. Therefore cost detail is unavailable and a financial comparison cannot be determined due to insufficient data and/or evidence.

Official sources